1) lung cancer with hydrothorax
肺癌并胸腔积液
2) lung cancer with pleural fluid
肺癌合并胸腔积液
1.
Objective It is to investigate the diagnostic value of the combined detection of CEA,Cyfra211,α1-AGP,CA125 for lung cancer with pleural fluid.
目的探讨血清和胸水CEA、Cyfra211、α1-AGP、CA125联合检测对肺癌合并胸腔积液的诊断价值。
3) lung cancer accompanied with hydrothorax
肺癌伴胸腔积液
5) Malignant pleural effusion
癌性胸腔积液
1.
Treatment of malignant pleural effusion using S_(311) anticancer vaccine by intrapleural injection;
S_(311)抗癌菌苗治疗癌性胸腔积液的临床研究
6) malignant pleural effusion and ascites
癌性胸/腹腔积液
1.
Methods: 125 Ser-rhIL-2 was administered subcutaneuously or intracavitarily in patients with advanced renal cell carcinoma, malignant melanoma or malignant pleural effusion and ascites.
其中癌性胸/腹腔积液和实体瘤患者分别为 141和 31例 ,有效率分别为 80 。
补充资料：癌性胸腔积液
癌性胸腔积液
malignant pleural effusion
指因胸膜、纵隔、肺原发或转移性肿瘤，致胸膜渗出增多，淋巴与静脉回流障碍引起的胸膜腔积液。多具有血性、低度渗出性，积液量大和渗出迅速等特点。治疗可穿刺抽液，闭式引流，胸内注射抗癌药或四环素封闭胸膜腔。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条